BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29024461)

  • 21. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA; Fisher J; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
    Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
    Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
    Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
    Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD43 in chronic lymphoproliferative leukemias.
    Sorigue M; Juncà J; Sarrate E; Grau J
    Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
    Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the CLLflow score.
    Sorigue M; Franch-Sarto M; Sarrate E; Junca J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
    Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of immunophenotype characteristics in 109 cases of B lineage chronic B lymphoid leukemia].
    Wang AQ; Geng MJ; Zhu MQ; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1374-7. PubMed ID: 22169286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Asplund SL; McKenna RW; Howard MS; Kroft SH
    Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of T-cell-associated markers CD4 and CD7 on B-cell chronic lymphocytic leukemia.
    Jani P; Qi XY; Chang H
    Am J Hematol; 2007 Jan; 82(1):73-6. PubMed ID: 17019687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic Leukemia.
    Afacan-Öztürk HB; Falay M; Albayrak M; Yıldız A; Öztürk ҪP; Maral S; Özet G
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia.
    Catovsky D
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):783-94, vii. PubMed ID: 15325698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
    Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
    Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
    El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
    Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.
    Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN
    Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics and clinical significance of immunophenotype in chronic lymphocytic leukemia].
    Kuang WY; Zhang GS; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):662-6. PubMed ID: 16114552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.